ArticleCureus2025
Mismatch Negativity and P300 in Children With Attention-Deficit/Hyperactivity Disorder (ADHD): A Comparative Event-Related Potential Study Using Healthy Siblings as Controls.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
AIM AND
backgroundAttention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder that involves attention, impulse control, and/or executive function difficulties. Knowledge of the neural bases underlying ADHD is essential for developing accurate diagnostic and treatment methods. This study assessed cognitive dysfunction in children with ADHD with respect to endophenotypic traits of event-related potentials (ERPs), specifically the mismatch negativity (MMN) and P300 components, and compared them to those of healthy siblings. These ERP components serve as neurophysiological markers of pre-attentive and attentive cognitive processes, respectively. MATERIALS AND
methodsThis observational cross-sectional study was conducted at Lady Hardinge Medical College, New Delhi, India, from November 2016 to January 2021. The study group comprised 18 children diagnosed with ADHD, who were compared to 10 healthy siblings serving as controls. ERPs were recorded using the SCHWARZER TOPAS EMG neurophysiological system (Schwarzer GmbH, Munich, Germany), which was triggered via a PC running the stimulus delivery software during an oddball paradigm of auditory stimuli. Post hoc pairwise comparisons across different electrode locations were used to evaluate the MMN and P300 components relative to their delays and amplitudes. Independent t-tests were used to assess differences in MMN and P300 latency and amplitude between the groups, with Cohen's d calculated to assess effect size.
resultsChildren with ADHD showed significantly prolonged latencies and reduced amplitudes in both the MMN and P300 components compared to their healthy controls. For example, MMN latency at Fz was 231.83±12.69 ms in the ADHD group and 196.60±11.53 ms in controls (P < 0.05), showing a strong effect size of 2.66, indicating a substantial difference between the two groups. In addition, there was a significant difference in the amplitude of P300 at the Fz site (µV) between ADHD children (4.28 ± 1.84) and controls (11.20 ± 3.29; p < 0.0001), with a large effect size of 2.98, favoring the control group. There were no correlations between Connors' ADHD Rating Scale subscores and any of the ERP variables.
conclusionThese results indicate that children with ADHD demonstrate significant neurophysiological differences in MMN and P300 components compared to their healthy siblings. While ERPs show potential as objective and quantifiable markers of cognitive dysfunction in ADHD, their utility as standalone diagnostic indices remains limited, especially given this study's small sample size and absence of correlation with behavioral severity. Larger studies are needed to confirm and extend these findings before ERPs can be reliably used in clinical diagnostics for ADHD.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.